Mersana Therapeutics
Scott David Collins has a solid background in Pharmacology, with experience in companies such as Mersana Therapeutics, Novartis Institutes for BioMedical Research, and AstraZeneca. Currently serving as the Director of Non-Clinical Development at Mersana Therapeutics, Scott David Collins has held various roles in Pharmacology and Toxicology Biology throughout their career. Additionally, Scott David has experience in the academic sector as a Student Ambassador at the University of Manchester.
Mersana Therapeutics
2 followers
Mersana is a biopharmaceutical company specializing in the discovery and development of antibody-drug conjugate (ADC) therapies to treat patients fighting cancer.